Log In
Print this Print this

AB+ICS (LAS40369)

  Manage Alerts
Collapse Summary General Information
Company Almirall S.A.
DescriptionCombination of aclidinium bromide and an inhaled corticosteroid (ICS)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today